EUVIMEDEUVIMED entdecken
Crossref

Agrimonia pilosa Extract suppresses NSCLC growth through regulating PI3K/AKT/Bcl-2 pathway

Ze-Hua Tong, Wen-Jun Guo, Ya-Juan Xu, Yue Zhang, Wei-Fang Wang

Journal of Ethnopharmacology · 2025

DOI: 10.1016/j.jep.2025.119892 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2025. Verfasst von Ze-Hua Tong und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun, 130117, PR China. Hauptthemen laut MEDLINE: Agrimonia, Plant Extracts, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Administration of Traditional Chinese Medicine of Jilin Province, Education Department of Jilin Province, Jilin Scientific and Technological Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: Agrimonia Pilosa is a traditional Chinese medicine with a long history, which is often used in clinic alone or in combined with other Chinese herb medicine to anti-inflammatory, hemostasis and treat many types cancers, including lung cancer. Agrimonia Pilosa Extract (APE) is extracted from the Agrimonia Pilosa. The potential molecular mechanism of APE on the non-small cell lung cancer remains unclear. AIM OF THIS STUDY: The aim of this study was to investigate the molecular mechanism of APE induced apoptosis in NSCLC cells and its effect on metabolism. MATERIALS AND METHODS: Constructed mouse transplantation tumor models to evaluate the anti-tumor effect of APE by pharmacodynamics test, histological staining and TUNEL staining. Analyzed alterations in metabolites and metabolic pathways in serum and tumor tissues from tumor-bearing mice by liquid chromatography-mass spectrometry (LC-MS)-based untargeted metabolomics. In addition, the key proteins and genes on the signaling pathway were verified by Western blotting (WB) and real-time fluorescence quantitative PCR(RT-qPCR) to reveal the anti-tumor mechanism of APE. RESULTS: APE inhibited tumor growth by promoting apoptosis and caused metabolic changes. Specifically, they inhibited the PI3K/AKT/Bcl-2 signaling pathway while upregulating apoptotic markers such as TP53, Bax, Caspase-3, and Cytochrome c. Through metabolomics analysis of mouse serum and tumor tissue, 120 different metabolites were identified, including glutamate, PC(24:0/18:0), and LysoPE (18:0/0). Among these, 13 serum metabolites were down-regulated, 16 were up-regulated, 28 tumor metabolites were down-regulated, and 63 were up-regulated. Studies indicate that APE can regulate metabolic disorders associated with non-small cell lung cancer by influencing pathways like glycerophospholipid metabolism, amino acid metabolism, and the TCA cycle, thereby inducing cell apoptosis and leading to significant metabolic changes. CONCLUSIONS: In this study, APE affected the apoptosis of non-small cell lung cancer cells by regulating the PI3K/AKT/Bcl-2 signal transduction pathway and various metabolic pathways thereby inhibited the growth of tumor cells.This deepened the understanding of the metabolic characteristics and apoptosis-related pathways in APE intervened NSCLC, and provided a reference for further research on the mechanism of action of its anticancer drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgrimoniaPlant ExtractsCarcinoma, Non-Small-Cell LungLung NeoplasmsAntineoplastic Agents, PhytogenicAnimalsProto-Oncogene Proteins c-aktHumansSignal TransductionProto-Oncogene Proteins c-bcl-2MiceApoptosisPhosphatidylinositol 3-KinasesCell ProliferationMice, Inbred BALB CCell Line, TumorMice, NudeXenograft Model Antitumor AssaysMale

Stichwörter der Autor:innen

A549cellsAgrimonia pilosa extractApoptosisMetabolomicsPI3K/AKT/Bcl-2 pathway

Substanzen

Proto-Oncogene Proteins c-aktPlant ExtractsProto-Oncogene Proteins c-bcl-2Antineoplastic Agents, PhytogenicPhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun, 130117, PR China.
  • Jilin Academy of Traditional Chinese Medicine Sciences, Jilin Changchun, 130012, PR China.
  • Department of Integrated Chinese and Western Medicine, Jilin Cancer Hospital, Changchun, 130012, PR China. Electronic address: zhangyuejlcc@163.com.
  • School of Clinical Medicine, Changchun University of Chinese Medicine, Changchun, 130117, PR China. Electronic address: wangwf@ccucm.edu.cn.

Förderung

  • Administration of Traditional Chinese Medicine of Jilin Province
  • Education Department of Jilin Province
  • Jilin Scientific and Technological Development Program

Zitieren

APA

Tong, Z. H., Guo, W. J., Xu, Y. J., Zhang, Y., & Wang, W. F. (2025). Agrimonia pilosa Extract suppresses NSCLC growth through regulating PI3K/AKT/Bcl-2 pathway. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2025.119892

Vancouver

Tong ZH, Guo WJ, Xu YJ, Zhang Y, Wang WF. Agrimonia pilosa Extract suppresses NSCLC growth through regulating PI3K/AKT/Bcl-2 pathway. Journal of Ethnopharmacology. 2025. doi:10.1016/j.jep.2025.119892

BibTeX
@article{Tong2025,
  author = {Tong, Ze-Hua and Guo, Wen-Jun and Xu, Ya-Juan and Zhang, Yue and Wang, Wei-Fang},
  title = {Agrimonia pilosa Extract suppresses NSCLC growth through regulating PI3K/AKT/Bcl-2 pathway},
  journal = {Journal of Ethnopharmacology},
  year = {2025},
  doi = {10.1016/j.jep.2025.119892}
}
Kostenlos starten →